Dr. Ed Park of Recharge Biomedical tendons and how they repair. He presents several cases of exosome use in tendinopathy
It appears that the benefits of tendon injection are gradual and continuous and are better at four weeks than at two weeks
DISCLAIMER: This website is for educational purposes only and is not for advertising. Telomerase activators and nanovesicles are not FDA-approved to prevent or treat any disease and anecdotes are not scientific proof of efficacy. All patients were treated in the context of a fully informed and legally-protected patient physician relationship.
Required fields
© 2020 Recharge Biomedical
Exosomes and TA-65 are not FDA-approved to prevent or treat any illness
